Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

165.40 -1.74 (-1.04%)
Streaming Delayed Price Updated: 11:20 AM EDT, Aug 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,914,920
Open 167.54
Bid (Size) 165.39 (2)
Ask (Size) 165.42 (6)
Prev. Close 167.14
Today's Range 165.16 - 167.94
52wk Range 155.72 - 186.69
Shares Outstanding 2,628,679,824
Dividend Yield 2.44%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Benzinga Before The Bell: Johnson & Johnson To Stop Selling Talc-Based Powder, Google Fined $43M In Australia For Misleading Users Over Data Tracking, S&P Global Drops Coinbase Debt Rating And Other Top Financial Stories Friday, August 12
Reuters 
Via Benzinga
Johnson & Johnson To Stop Selling Talc-Based Powder
 
Via Benzinga

Performance

YTD
-3.58%
-3.58%
1 Month
-5.94%
-5.94%
3 Month
-7.01%
-7.01%
6 Month
-2.37%
-2.37%
1 Year
-4.83%
-4.83%

More News

Read More
Stocks Take Pause Despite Surprise Drop In Inflation Data
Via Talk Markets
Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke
Via Benzinga
Blue Chip Stocks In Focus: Johnson & Johnson
Via Talk Markets
Agilis Consulting Group Appoints Former Johnson & Johnson Employee, Denise Wagner, as Principal Human Factors Consultant
Via Newswire.com
Covid Exposed A 'Brain Health Pandemic' — Here's How Biotech Stocks Like Biogen, Sage Therapeutics Could Help
Via Investor's Business Daily
The 3 Best Sectors for a Bear Market
Via InvestorPlace
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
Via Investor Brand Network
Exposures Product Safety
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
Via FinancialNewsMedia
Exposures Product Safety
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Via MarketBeat
Topics ETFs
Exposures COVID-19
Why Is Novavax (NVAX) Stock Plunging 30%?
Via InvestorPlace
3 Dividend Stocks to Buy to Beat Runaway Inflation
Via InvestorPlace
The 3 Best Vanguard Funds to Buy in August
Via InvestorPlace
Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
From Johnson & Johnson
Via Business Wire
3 Blue-Chip Stocks With Rock-Solid Dividends
Via Talk Markets
Is Church & Dwight Co. Inc. (NYSE: CHD) a Buy for Dividend Investors?
Via MarketBeat
Johnson & Johnson Whale Trades Spotted
Via Benzinga
Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference
From Johnson & Johnson
Via Business Wire
Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus
Via Benzinga
Biotech Investors: August's Key PDUFA Catalysts You Must Know
Via Benzinga
Top 5 High-Quality Dividend Growth “Forever Stocks” To Buy
Via Talk Markets
Best Stocks To Hold For The Recession
Via Talk Markets
7 Blue-Chip Stocks to Buy Before the Bull Market Returns
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.